💊 Medicine AT September 16, 2026

Sandimmun Neoral 50 mg - Kapseln 50 mg (Weichkapsel)

📷 Wikipedia: Ciclosporin · Source

ATC: L04AD01
Reason: Verzögerung bei der Herstellung
Marketing authorisation holder: Novartis Pharma GmbH, Jakov-Lind-Straße 5/Top 3.05, 1020 Wien, Österreich
Affected packs: 50 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since 2026-09-03, resupply 2026-10-12]

⚠️

Shortage ongoing

CICLOSPORIN is currently in short supply in AT.

📈 Timeline

2 days active so far

September 17, 2026 September 18, 2026

A plain-language summary will appear here shortly. Read the official notice below.

🔬 Medical / technical details (for professionals)

Active substance(s)

CICLOSPORIN

Agency-published detail

🚫 Parallel export ban active · ATC: L04AD01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Novartis Pharma GmbH, Jakov-Lind-Straße 5/Top 3.05, 1020 Wien, Österreich · Affected packs: 50 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since 2026-09-03, resupply 2026-10-12]

First published

September 16, 2026

Last refreshed by us

8 hours ago

Severity (as classified)

Medium

Official source

https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

🔔 Stay informed

Get an email if there's an update.

Free · One click to unsubscribe

📤 Tell someone

🦋 Bluesky 𝕏 🐘 💬 WhatsApp ✈️ Telegram ✉️ Email

📋 Quick facts

Status

Shortage ongoing

Affects

First detected by us

September 17, 2026

Agency-reported start

September 16, 2026

Days active

Related alerts

Medium AT 2 days ago

Sandimmun Neoral 100 mg - Kapseln 100 mg (Weichkapsel)

Medium AT 3 months ago

IKERVIS 1 mg/ml Augentropfen, Emulsion 1 mg/ml (Augentropfen, Emulsion)

IKERVIS 1 mg/ml eye drops, emulsion is subject to a parallel export ban.

Low AT resolved 4 months ago

Neoimmun 25 mg - Kapseln 25 mg (Weichkapsel)

Neoimmun 25 mg capsules (soft capsules) 25 mg are unavailable due to a manufacturing delay.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?

Sandimmun Neoral 50 mg - Kapseln 50 mg (Weichkapsel). 🚫 Parallel export ban active · ATC: L04AD01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Novartis Pharma GmbH, Jakov-Lind-Straße 5/Top 3.05, 1020 Wien, Österreich · Affected packs: 50 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since...

▸ When was this alert issued?

This alert was issued on September 16, 2026 by BASG (Austria).

▸ Which countries are affected?

The alert applies to Austria.

▸ How serious is this alert?

Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.

▸ What should I do?

If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.

▸ Where can I find the official notice?

The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.